Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Highly Sensitized Patients Awaiting Kidney Transplant”

12 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 12 of 12 results

Early research (Phase 1)Looking for participantsNCT06056102
What this trial is testing

CAR-T Cell Therapy for Desensitization in Kidney Transplantation

Who this might be right for
Kidney TransplantKidney FailureEnd Stage Renal Failure on Dialysis
National Institute of Allergy and Infectious Diseases (NIAID) 20
Testing effectiveness (Phase 2)WithdrawnNCT04174677
What this trial is testing

Safety and Tolerability of Inebilizumab, VIB4920, or the Combination in Highly Sensitized Candidates Awaiting Kidney Transplantation From a Deceased Donor

Who this might be right for
Highly Sensitized Patients on Waiting List for Kidney Transplantation
Amgen
Testing effectiveness (Phase 2)Study completedNCT00642655
What this trial is testing

Rituximab and Intravenous Immunoglobulin (IVIG) for Desensitization in Renal Transplantation

Who this might be right for
Kidney Transplant
Cedars-Sinai Medical Center 20
Testing effectiveness (Phase 2)Study completedNCT02426684
What this trial is testing

Ides in Highly Sensitized (HS) Patients Awaiting Kidney Transplantation

Who this might be right for
Renal Disease
Cedars-Sinai Medical Center 17
Not applicableUnknownNCT05785936
What this trial is testing

Immune Response in Desensitized Patients

Who this might be right for
Kidney Transplant Rejection
University Hospital, Grenoble 20
Testing effectiveness (Phase 2)Study completedNCT00446459
What this trial is testing

Effects of Mycophenolate Mofetil (MMF) On Anti-HLA (Human Leukocyte Antigen)Antibody Levels In Patients Awaiting Cadaveric Renal Transplant.

Who this might be right for
Kidney Failure, ChronicDiabetic NephropathiesGlomerulonephritis, IGA+1 more
University of Washington 45
Very early researchNot Yet RecruitingNCT07350837
What this trial is testing

CAR-T Therapy Targeting CD19 and BCMA in Highly Sensitized Kidney Transplant Participants

Who this might be right for
Highly Sensitized Patients Awaiting Kidney Transplant
Tongji Hospital 12
Testing effectiveness (Phase 2)Ended earlyNCT05145296
What this trial is testing

The Safety/Efficacy Of Daratumumab With Belatacept In Highly HLA-Sensitized Patients Awaiting Kidney Transplantation

Who this might be right for
SensitisationHighly Sensitised Dialysis Patients
University Hospital, Grenoble 5
Testing effectiveness (Phase 2)Active Not RecruitingNCT03380962
What this trial is testing

Clazakizumab in Highly-HLA Sensitized Patients Awaiting Renal Transplant

Who this might be right for
Kidney Failure, ChronicEnd-Stage Renal DiseaseTransplant Glomerulopathy+4 more
Stanley Jordan, MD 20
Testing effectiveness (Phase 2)Study completedNCT00446251
What this trial is testing

Effects of Rituximab and Mycophenolate Mofetil (MMF) on Highly Sensitized Patients Awaiting Renal Transplant

Who this might be right for
Kidney Failure, ChronicDiabetic NephropathiesGlomerulonephritis, IGA+1 more
University of Washington 14
Testing effectiveness (Phase 2)Study completedNCT01594424
What this trial is testing

A Safety Study of Tocilizumab to Improve Transplant Rates in Highly Sensitized Patients Awaiting Kidney Transplantation

Who this might be right for
End Stage Renal Disease (ESRD)
Cedars-Sinai Medical Center 10
Testing effectiveness (Phase 2)Study completedNCT01178216
What this trial is testing

Use of Immune Globulin Plus Rituximab for Desensitization in Highly HLA Sensitized Patients Awaiting Deceased Donor Kidney Transplantation

Who this might be right for
End Stage Renal Disease
Stanley Jordan, MD 41